Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 198,840,320
  • Shares Outstanding, K 2,044,000
  • Annual Sales, $ 46,660 M
  • Annual Income, $ 14,850 M
  • 60-Month Beta 0.54
  • Price/Sales 4.28
  • Price/Cash Flow 8.49
  • Price/Book 4.13
Trade NVS with:

Options Overview Details

View History
  • Implied Volatility 17.26% ( -0.29%)
  • Historical Volatility 16.60%
  • IV Percentile 44%
  • IV Rank 35.35%
  • IV High 25.21% on 04/19/24
  • IV Low 12.92% on 12/05/23
  • Put/Call Vol Ratio 0.35
  • Today's Volume 1,156
  • Volume Avg (30-Day) 3,354
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 60,173
  • Open Int (30-Day) 50,263

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 1.73
  • Number of Estimates 3
  • High Estimate 1.77
  • Low Estimate 1.71
  • Prior Year 1.71
  • Growth Rate Est. (year over year) +1.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.35 +5.58%
on 04/18/24
99.50 -2.01%
on 04/23/24
+1.27 (+1.32%)
since 03/22/24
3-Month
92.35 +5.58%
on 04/18/24
107.96 -9.69%
on 01/29/24
-10.05 (-9.34%)
since 01/24/24
52-Week
92.19 +5.76%
on 10/27/23
108.78 -10.37%
on 01/22/24
-3.09 (-3.07%)
since 04/24/23

Most Recent Stories

More News
Why Novartis Stock Topped the Market on Tuesday

A double beat on the latest quarterly results and raised guidance made investors happy.

NVS : 97.60 (+0.33%)
Novartis, Danaher rise; Nucor, Cadence Design Systems fall, Tuesday, 4/23/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Novartis, Danaher rise; Nucor, Cadence Design Systems fall

NUE : 173.43 (-0.69%)
GM : 44.75 (-0.78%)
CDNS : 279.49 (-0.81%)
DHR : 248.63 (-1.77%)
NVS : 97.60 (+0.33%)
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript

NVS earnings call for the period ending March 31, 2024.

NVS : 97.60 (+0.33%)
Novartis: Q1 Earnings Snapshot

Novartis: Q1 Earnings Snapshot

NVS : 97.60 (+0.33%)
2 High-Yield Dividend Stocks to Buy and Hold for 10 Years

These income stocks look like good options at current levels.

BMY : 48.65 (-0.69%)
NVS : 97.60 (+0.33%)
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.

Think globally with this high-yielding ETF.

TM : 232.26 (+0.80%)
NVS : 97.60 (+0.33%)
HSBC : 41.53 (-0.86%)
SHEL : 72.66 (-0.15%)
RHHBY : 30.3400 (-2.88%)
VYMI : 67.61 (-0.63%)
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024

Stocks that traded heavily or had substantial price changes on Thursday: Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise

ALPN : 64.58 (+0.05%)
CONN : 3.76 (+1.52%)
NTIC : 16.11 (-0.74%)
BTUUQ : 1.1924 (+211.33%)
BTU : 23.15 (-1.24%)
NVS : 97.60 (+0.33%)
KMX : 70.04 (+0.50%)
FAST : 67.64 (+0.77%)
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster...

AZN : 71.12 (+0.38%)
FUSN : 21.37 (-0.23%)
NVS : 97.60 (+0.33%)
LLY : 730.94 (-1.98%)
BMY : 48.65 (-0.69%)
Health Canada grants approval of the Eye-Tracking Neurological Assessment for Multiple Sclerosis (ETNAâ„¢-MS) for use in tracking disease progression in people living with MS

More than 90,000 Canadians—or one in 400 people across Canada—live with multiple sclerosis (MS),1 a neurodegenerative, chronic condition that affects the...

NVS : 97.60 (+0.33%)
1 Magnificent Dividend Stock to Buy and Hold

The company's business went through some important changes last year.

NVS : 97.60 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 101.31
2nd Resistance Point 100.41
1st Resistance Point 98.84
Last Price 97.60
1st Support Level 96.37
2nd Support Level 95.47
3rd Support Level 93.90

See More

52-Week High 108.78
Fibonacci 61.8% 102.44
Fibonacci 50% 100.49
Fibonacci 38.2% 98.53
Last Price 97.60
52-Week Low 92.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar